Form 4: Immunovant CFO Sells Shares to Cover Tax Obligations

Eva Renee Barnett, CFO of Immunovant, Inc., sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On August 21, 2024, Eva Renee Barnett, the Chief Financial Officer of Immunovant, Inc., sold 3,619 shares of common stock at a weighted average price of $31.84 and 149 shares of common stock at a weighted average price of $32.32.
• These sales were to cover tax withholding obligations related to the vesting of 7,051 restricted stock units (RSUs) on August 17, 2024, which were part of a grant of 112,816 RSUs from August 17, 2022.
• The sales were mandated by Immunovant's policy requiring tax obligations to be funded by a 'sell to cover' transaction and do not represent a discretionary transaction by Barnett.
• Following the reported transactions, Barnett still beneficially owns 343,776 shares of Immunovant common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and tax obligations, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes upon the vesting of stock awards.

Key Dates